Bris­tol My­ers to shut­ter Bay Area cell ther­a­py R&D fa­cil­i­ty as it elim­i­nates jobs and costs

Bris­tol My­ers Squibb is clos­ing a cell ther­a­py R&D site in Cal­i­for­nia as the com­pa­ny im­ple­ments a $1.5 bil­lion cost-cut­ting pro­gram that was an­nounced this week, ac­cord­ing to a com­pa­ny spokesper­son.

The Red­wood City, CA fa­cil­i­ty will be closed and em­ploy­ees who aren’t be­ing let go will be re­lo­cat­ed to an­oth­er site in Bris­bane, al­so in the Bay Area. The changes come amid lay­offs of rough­ly 2,200 em­ploy­ees com­pa­ny-wide, rep­re­sent­ing about 6% of its glob­al work­force, and a pipeline re­or­ga­ni­za­tion as new CEO Chris Boern­er steers Bris­tol My­ers through a “tran­si­tion pe­ri­od” fol­low­ing sev­er­al big ac­qui­si­tions.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER